Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 9,854 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jun 12 to Jun 15, 2026 · Filed Jun 15, 2026

From Jun 12 to Jun 15, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 9,854 Oruka Therapeutics, Inc. shares at an average US$69.72 for US$687K under a trading plan, leaving 16,899 shares. Filed Jun 15, 2026 (Form 4).

Sold: 9,854 shares
Price: US$69.72 average (US$68.34 to US$70.34)
Value: US$687K
Holding after: 16,899 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Senior Vice President, Finance

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 12, 2026	Common Stock	Option exercise	8,000	US$12.50	25,294	Direct
Jun 12, 2026	Common Stock	Option exercise	1,459	US$34.39	26,753	Direct
Jun 12, 2026	Common Stock	Sale	1,859	US$68.34	24,894	Direct
Jun 12, 2026	Common Stock	Sale	4,340	US$69.85	20,554	Direct
Jun 12, 2026	Common Stock	Sale	3,260	US$70.34	17,294	Direct
Jun 15, 2026	Common Stock	Sale	395	US$69.69	16,899	Direct

Source

View original at SEC

Related